MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi)

Ann Hematol. 2011 Jul;90(7):847-9. doi: 10.1007/s00277-010-1099-6. Epub 2010 Oct 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / genetics*
  • Leukemia / pathology
  • Leukemia / physiopathology
  • Male
  • Middle Aged
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Remission Induction
  • Treatment Outcome

Substances

  • Histone Deacetylase Inhibitors
  • Myeloid-Lymphoid Leukemia Protein